Stocksigma LogoStocksigma Logo

Morepen Laboratories Completes Phase 1 Capacity Expansion Ahead of Schedule

Morepen Laboratories Limited announced on 7th Sep'26 that it has completed the first phase of its manufacturing capacity expansion ahead of schedule

Morepen Laboratories Completes Phase 1 Capacity Expansion Ahead of Schedule

Morepen Laboratories Ltd 路 Others (Uncategorized) 路 07 Sept 2026, 2:23 pm

Morepen Laboratories Completes Phase 1 Capacity Expansion Ahead of Schedule Morepen Laboratories Limited announced on 7th Sep'26 that it has completed the first phase of its manufacturing capacity expansion ahead of schedule. The company's installed reactor capacity for API and CDMO operations expanded from 535 KL to 614 KL. This enhancement strengthens manufacturing readiness for scaling up commercial CDMO supplies, supports the existing API business, and facilitates future customer programs as part of its strategy to build a scalable, globally compliant platform.

Original exchange filing (PDF)

More announcements from Morepen Laboratories Ltd

All Morepen Laboratories Ltd announcements